comparemela.com

Page 15 - Artivion News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2021 Financial Results

/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and.

United statesD ashley leePat mackinBrian johnston lynn lewisGilmartin groupArtivion incPrnewswire artivion incChief executive officerInvestor relationsVice presidentChief financial officerChief operating officerLynn lewis

Artivion Announces Publication of On-X® Mitral Heart Valve PROACT Study Results in The Annals of Thoracic Surgery

/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the publication of.

United statesCity ofUnited kingdomMichael wa chuD ashley leePat mackinBrian johnston lynn lewisSociety of thoracic surgeons onSurgery at london health sciences centreDrug administrationPrnewswire artivion incSociety of thoracic surgeon annual meetingGilmartin groupArtivion incSociety of thoracic surgeonsThoracic surgery

CryoLife Becomes Artivion as Part of Rebranding Initiative

January 18, 2022—CryoLife, Inc. announced that it was renaming and rebranding itself to Artivion, Inc., effective immediately. Effective January

New yorkUnited statesNew york stock exchangePat mackinYork stock exchangeArtivion incCryolife incChief executive officerAnalyst dayRtivion comPat mackinAortic stentsStent graftsProsthetic heart valvesRyoperserved cardiac and vascular allograftsSurgical sealants

vimarsana © 2020. All Rights Reserved.